In the ER+ cohort, similarly, low nuclear MRE11 was strongly linked with poor BCSS (p = 0.00006) (Fig. 2b) but not in ER− tumours (p = 0.121) (Fig. 2c). Here, MRE11 is linked to neoplasm.